Welcome to our dedicated page for RIDGETECH news (Ticker: RDGT), a resource for investors and traders seeking the latest updates and insights on RIDGETECH stock.
Ridgetech, Inc. (NASDAQ: RDGT) is a Cayman Islands healthcare company that focuses on the online and offline wholesale distribution of pharmaceutical and other healthcare products in China. Its news flow reflects developments in its wholesale pharmaceutical business, financial performance and corporate actions as a foreign private issuer listed on the Nasdaq Stock Market.
Readers of the RDGT news page can follow company announcements about its strategic shift away from retail pharmacy operations toward wholesale distribution, including updates related to the acquisition and integration of Ridgeline and its subsidiary Allright (Hangzhou) Internet Technology Co. Ltd. Ridgetech’s disclosures describe Allright as a rapidly growing online and offline wholesale distributor of pharmaceutical and other healthcare products such as health foods, cosmetics and daily necessities in China, and news items may highlight how this network contributes to the company’s revenue and business opportunities.
The news feed also features earnings and financial results, where Ridgetech discusses revenue trends, gross margins, operating income or loss, and the impact of discontinued retail operations under ASC 205. These releases provide context on the performance of its offline wholesale and online platform segments, as well as commentary from management on market competition and the company’s resource allocation toward wholesale activities.
In addition, Ridgetech’s news includes capital markets and governance updates, such as private placements of ordinary shares and warrants, shareholder rights agreements, and outcomes of annual general meetings. Items may cover shareholder approvals for director elections, auditor ratification, share consolidations and amendments to its memorandum and articles of association, along with changes to equity incentive plans. Investors and researchers can use this page as a central source for company-issued information on Ridgetech’s operations, strategy, financing activities and corporate governance decisions.
Ridgetech (NASDAQ:RDGT) reported its fiscal year 2025 results, marked by strategic transformation. Revenue reached $119.97 million, a slight decrease of 3.2% from the previous year. The company reported net income of $10.20 million ($1.84 per share), compared to a net loss of $4.23 million in FY2024.
Key developments include the divestiture of retail pharmacy operations and the acquisition of Ridgeline and Allright, marking expansion into online wholesale distribution. The newly acquired online platform contributed 1% of total revenue with a 7.4% gross margin. Overall gross margin decreased to 3.2% from 3.9% year-over-year, while sales and marketing expenses increased by 64.2%.
The company's cash position strengthened to $12.78 million as of March 31, 2025, up from $2.30 million the previous year, with operating activities providing $1.25 million in cash flow.
FAQ
What is the current stock price of RIDGETECH (RDGT)?
What is the market cap of RIDGETECH (RDGT)?
